Plasma Protease C1-inhibitor Treatment Market Report

Global Plasma Protease C1-inhibitor Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jun 04, 2021
  • PAGES：235
  • REPORT CODE：GMM694602
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Plasma Protease C1-inhibitor Treatment Market is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Plasma Protease C1-inhibitor Treatment market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Plasma Protease C1-inhibitor Treatment industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Plasma Protease C1-inhibitor Treatment Market Segmentations:

    By Players:

    • Centogene AG

    • Pharming Technologies BV

    • CSL Behring LLC

    • BioCryst Pharmaceuticals

    • KalVista Pharmaceuticals, Inc

    • Takeda Pharmaceutical Company Limited

    • Ionis Pharmaceuticals, Inc

    By Types:

    • C1-inhibitors

    • Kallikrein Inhibitor (Kalbitor)

    By End-User:

    • Hospital Pharmacies

    • Independent Pharmacies and Outlets

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Plasma Protease C1-inhibitor Treatment Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of C1-inhibitors from 2014 to 2026

      • 1.3.2 Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Kallikrein Inhibitor (Kalbitor) from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

      • 1.4.2 Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Independent Pharmacies and Outlets from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Plasma Protease C1-inhibitor Treatment Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Plasma Protease C1-inhibitor Treatment by Major Types

      • 3.4.1 Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of C1-inhibitors

      • 3.4.2 Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Kallikrein Inhibitor (Kalbitor)

    4 Segmentation of Plasma Protease C1-inhibitor Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Plasma Protease C1-inhibitor Treatment by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Plasma Protease C1-inhibitor Treatment in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Plasma Protease C1-inhibitor Treatment in Independent Pharmacies and Outlets

    5 Market Analysis by Major Regions

    • 5.1 Global Plasma Protease C1-inhibitor Treatment Production Analysis by Major Regions

    • 5.2 Global Plasma Protease C1-inhibitor Treatment Consumption Analysis by Major Regions

    • 5.3 Global Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis

    6 Product Commodity of Plasma Protease C1-inhibitor Treatment Market in Major Countries

    • 6.1 Top 5 Export Countries in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Plasma Protease C1-inhibitor Treatment Landscape Analysis

    • 7.1 North America Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Types

    • 7.2 North America Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major End-Users

    • 7.3 North America Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Countries

      • 7.3.1 United States Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 7.3.2 Canada Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 7.3.3 Mexico Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

    8 Europe Plasma Protease C1-inhibitor Treatment Landscape Analysis

    • 8.1 Europe Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Types

    • 8.2 Europe Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major End-Users

    • 8.3 Europe Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Countries

      • 8.3.1 Germany Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.2 UK Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.3 France Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.4 Italy Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.6 Spain Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.7 Belgium Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.8 Poland Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.9 Russia Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 8.3.10 Turkey Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

    9 Asia Pacific Plasma Protease C1-inhibitor Treatment Landscape Analysis

    • 9.1 Asia Pacific Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Types

    • 9.2 Asia Pacific Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Countries

      • 9.3.1 China Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 9.3.2 Japan Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 9.3.4 India Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 9.3.6 South Korea Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 10.3.2 Brazil Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 10.3.3 Nigeria Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

      • 10.3.4 South Africa Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate 

      • 10.3.5 Argentina Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Centogene AG

      • 11.1.1 Centogene AG Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Pharming Technologies BV

      • 11.2.1 Pharming Technologies BV Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 CSL Behring LLC

      • 11.3.1 CSL Behring LLC Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 BioCryst Pharmaceuticals

      • 11.4.1 BioCryst Pharmaceuticals Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 KalVista Pharmaceuticals, Inc

      • 11.5.1 KalVista Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Takeda Pharmaceutical Company Limited

      • 11.6.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Ionis Pharmaceuticals, Inc

      • 11.7.1 Ionis Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 94 Figures and 146 Tables)

    • Figure Product Picture

    • Figure Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of C1-inhibitors from 2014 to 2026

    • Figure Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Kallikrein Inhibitor (Kalbitor) from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Independent Pharmacies and Outlets from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Plasma Protease C1-inhibitor Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Plasma Protease C1-inhibitor Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Plasma Protease C1-inhibitor Treatment by Different Types from 2014 to 2026

    • Table Consumption Share of Plasma Protease C1-inhibitor Treatment by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of C1-inhibitors

    • Figure Market Size and Growth Rate of Kallikrein Inhibitor (Kalbitor)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Plasma Protease C1-inhibitor Treatment by Different End-Users from 2014 to 2026

    • Table Consumption Share of Plasma Protease C1-inhibitor Treatment by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Independent Pharmacies and Outlets

    • Table Global Plasma Protease C1-inhibitor Treatment Production by Major Regions

    • Table Global Plasma Protease C1-inhibitor Treatment Production Share by Major Regions

    • Figure Global Plasma Protease C1-inhibitor Treatment Production Share by Major Regions in 2014

    • Figure Global Plasma Protease C1-inhibitor Treatment Production Share by Major Regions in 2018

    • Figure Global Plasma Protease C1-inhibitor Treatment Production Share by Major Regions in 2026

    • Table Global Plasma Protease C1-inhibitor Treatment Consumption by Major Regions

    • Table Global Plasma Protease C1-inhibitor Treatment Consumption Share by Major Regions

    • Figure Global Plasma Protease C1-inhibitor Treatment Consumption Share by Major Regions in 2014

    • Figure Global Plasma Protease C1-inhibitor Treatment Consumption Share by Major Regions in 2018

    • Figure Global Plasma Protease C1-inhibitor Treatment Consumption Share by Major Regions in 2026

    • Table North America Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis

    • Table Europe Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Plasma Protease C1-inhibitor Treatment market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Plasma Protease C1-inhibitor Treatment Consumption by Types from 2014 to 2026

    • Table North America Plasma Protease C1-inhibitor Treatment Consumption Share by Types from 2014 to 2026

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2014

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2018

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2026

    • Table North America Plasma Protease C1-inhibitor Treatment Consumption by End-Users from 2014 to 2026

    • Table North America Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2014

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2018

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2026

    • Table North America Plasma Protease C1-inhibitor Treatment Consumption by Major Countries from 2014 to 2026

    • Table North America Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2014

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2018

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2026

    • Figure United States Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Plasma Protease C1-inhibitor Treatment Consumption by Types from 2014 to 2026

    • Table Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Types from 2014 to 2026

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2014

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2018

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2026

    • Table Europe Plasma Protease C1-inhibitor Treatment Consumption by End-Users from 2014 to 2026

    • Table Europe Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2014

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2018

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2026

    • Table Europe Plasma Protease C1-inhibitor Treatment Consumption by Major Countries from 2014 to 2026

    • Table Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2014

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2018

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2026

    • Figure Germany Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure France Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption by Types from 2014 to 2026

    • Table Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2014

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2018

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2026

    • Table Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2014

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2018

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2026

    • Table Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2026

    • Figure China Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandPlasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure India Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Plasma Protease C1-inhibitor Treatment Consumption Share by Major Countries in 2026

    • Figure GCC Countries Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Plasma Protease C1-inhibitor Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Centogene AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Centogene AG

    • Figure Sales and Growth Rate Analysis of Centogene AG

    • Figure Revenue and Market Share Analysis of Centogene AG

    • Table Product and Service Introduction of Centogene AG

    • Table Company Profile and Development Status of Pharming Technologies BV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharming Technologies BV

    • Figure Sales and Growth Rate Analysis of Pharming Technologies BV

    • Figure Revenue and Market Share Analysis of Pharming Technologies BV

    • Table Product and Service Introduction of Pharming Technologies BV

    • Table Company Profile and Development Status of CSL Behring LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring LLC

    • Figure Sales and Growth Rate Analysis of CSL Behring LLC

    • Figure Revenue and Market Share Analysis of CSL Behring LLC

    • Table Product and Service Introduction of CSL Behring LLC

    • Table Company Profile and Development Status of BioCryst Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCryst Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of BioCryst Pharmaceuticals

    • Figure Revenue and Market Share Analysis of BioCryst Pharmaceuticals

    • Table Product and Service Introduction of BioCryst Pharmaceuticals

    • Table Company Profile and Development Status of KalVista Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of KalVista Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of KalVista Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of KalVista Pharmaceuticals, Inc

    • Table Product and Service Introduction of KalVista Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

    • Table Company Profile and Development Status of Ionis Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals, Inc

    • Table Product and Service Introduction of Ionis Pharmaceuticals, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US